{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fpodcast.allohopefoundation.org%2Fepisodes%2Fmyths-and-management-of-severe-disease-ly1ZYsdL","width":444,"version":"1.0","type":"rich","title":"Myths and Management of Severe Disease","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/c01c2769-57c9-4c26-ad99-4e81b33fa3b1/27260c21-e5fa-4cbe-8b1b-5714ad2bf775/the-allo-podcast.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/46cfff72-ddad-44b6-8b29-b0510599f41e\" height=\"200\" width=\"100%\" title=\"Myths and Management of Severe Disease\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Severe alloimmunization is surrounded by vague information and confusion, but this episode will prepare patients and providers for available treatment. Patients with previous fetal death, previous IUT before 24 weeks, or with a titer of 256 or higher may be diagnosed with severe disease. Remember, options do exist for severe situations, and prevention and monitoring are the key elements to having a healthy baby. This episode discusses IVIG and plasmapheresis, early MCA Scans and early IUTs, and phenobarbital. "}